Low-density lipoprotein (LDL) particles are known as atherogenic agents in coronary artery
diseases. They modify to other electronegative forms and may be the subject for …

Both cholesterol esters (CE) and triacylglycerols (TG) are insoluble in water (plasma); hence
they are packaged as lipoproteins comprising an inner core of CE and TG with a surface …

The LDLR family of proteins is involved in lipoproteins trafficking. While the role of LDLR in
cardiovascular disease has been widely studied, only recently the role of other members of …

The low density lipoprotein particle is the major transporter of cholesterol around the body
and has been shown to be a strong independent risk factor for atherosclerotic events. This …

The aim of this work is to present basic information on the lipoprotein physiology. The
protein fraction of lipoproteins consists of several apolipoproteins and enzymes whose …

During the past few years considerable advances have been made in the study of
mammalian plasma low density lipoproteins. Although human LDL is of prime interest …

The five different types of lipoproteins are chylomicrons, very-low-density lipoprotein (VLDL),
intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL), and HDL. Lipoproteins …

There is a strong association between increased blood concentrations of low-density
lipoprotein (LDL) and severity of coronary atherosclerosis. Multiple mechanisms affect …

Modified forms of low density lipoprotein (LDL) are associated with increased atherogenicity.
Modified LDL, in comparison with native LDL, demonstrates enhanced cellular uptake by …

Among the diseases causing human death, cardiovascular disease (CVD) remains number
one according to the World Health Organization report in 2021. It is known that …